Prime Medicine, Inc. (PRME)
3.13
-0.22
(-6.57%)
USD |
NASDAQ |
Sep 11, 16:00
3.125
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Price : 3.13 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 3.38 | 3.44 | 3.10 | 3.13 | 3.077M |
| Sep 10, 2026 | 3.37 | 3.42 | 3.31 | 3.35 | 2.390M |
| Sep 09, 2026 | 3.47 | 3.535 | 3.29 | 3.47 | 4.225M |
| Sep 08, 2026 | 3.65 | 3.65 | 3.41 | 3.56 | 3.602M |
| Sep 04, 2026 | 3.83 | 3.86 | 3.65 | 3.70 | 1.619M |
| Sep 03, 2026 | 3.70 | 3.72 | 3.49 | 3.71 | 2.313M |
| Sep 02, 2026 | 3.50 | 3.705 | 3.47 | 3.67 | 2.474M |
| Sep 01, 2026 | 3.54 | 3.71 | 3.48 | 3.57 | 2.459M |
| Aug 31, 2026 | 3.54 | 3.635 | 3.460 | 3.59 | 2.093M |
| Aug 28, 2026 | 3.57 | 3.70 | 3.48 | 3.61 | 2.694M |
| Aug 27, 2026 | 3.55 | 3.665 | 3.48 | 3.64 | 1.833M |
| Aug 26, 2026 | 3.66 | 3.66 | 3.435 | 3.58 | 1.952M |
| Aug 25, 2026 | 3.30 | 3.71 | 3.285 | 3.71 | 3.321M |
| Aug 24, 2026 | 3.38 | 3.40 | 3.195 | 3.25 | 2.268M |
| Aug 21, 2026 | 3.26 | 3.49 | 3.24 | 3.39 | 3.603M |
| Aug 20, 2026 | 3.43 | 3.50 | 3.20 | 3.24 | 3.798M |
| Aug 19, 2026 | 3.29 | 3.59 | 3.25 | 3.54 | 6.791M |
| Aug 18, 2026 | 3.10 | 3.199 | 3.02 | 3.05 | 1.271M |
| Aug 17, 2026 | 3.07 | 3.19 | 3.020 | 3.17 | 1.501M |
| Aug 14, 2026 | 3.14 | 3.14 | 3.00 | 3.09 | 1.571M |
| Aug 13, 2026 | 3.23 | 3.285 | 3.13 | 3.17 | 1.889M |
| Aug 12, 2026 | 3.24 | 3.305 | 3.17 | 3.20 | 1.444M |
| Aug 11, 2026 | 3.20 | 3.29 | 3.085 | 3.26 | 2.258M |
| Aug 10, 2026 | 3.09 | 3.315 | 3.06 | 3.15 | 3.596M |
| Aug 07, 2026 | 3.00 | 3.12 | 2.97 | 3.08 | 1.977M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Beam Therapeutics, Inc. | 23.99 |
| Twist Bioscience Corp. | 127.22 |
| Intellia Therapeutics, Inc. | 11.74 |
| Revolution Medicines, Inc. | 203.77 |
| Sana Biotechnology, Inc. | 3.13 |
Price Related Metrics
| PS Ratio | 133.59 |
| Price to Book Value | 14.21 |
| Earnings Yield | -34.68% |
| Market Cap | 565.71M |